The cost-share agreement will fund development and FDA clearance of the OXOS X3, a next-generation device designed for point-of-need imaging in emergency and mass casualty settings.
Konica Minolta Healthcare Americas Inc. announces that it will introduce its compact, point-of-care ultrasound system, SonImage MX1 Platinum, at the 2022 Annual Meeting of the Radiological Society of North America, which takes place from November 27-December 1 in Chicago.
Most of the initiatives to protect the well-being of healthcare workers on the frontlines of the COVID-19 pandemic have focused on access to high-quality personal protective equipment. However, some argue that a major component is being overlooked: behavioral health.
The cost-share agreement will fund development and FDA clearance of the OXOS X3, a next-generation device designed for point-of-need imaging in emergency and mass casualty settings.
Computer algorithms analyzing digital pathology slide images were shown to detect the spread of cancer to lymph nodes in women with breast cancer as well as or better than pathologists, in a new study published online in the Journal of the American Medical Association.
Read More
In a statement, U.S. FDA Commissioner Scott Gottlieb, MD, revealed that the FDA has completed its first qualification of a medical device development tool to provide a more objective platform for developing devices in a key area of medicine: cardiovascular health.
Read More
The global mobile health sector is poised to grow 32.3% over the next decade to reach approximately $189 billion by 2025. Some of the prominent trends that the market is witnessing include an increasing awareness of mobile-based medical devices, a surging focus on patient-centric healthcare delivery, and more.
Read More
Accuray Inc., based in Sunnyvale, Calif., has announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4% had local disease control 10 years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife system, and toxicity was mild.
Read More
The U.S. FDA has authorized use of Cook Medical’s Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to 1 year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.
Read More
According to a new report from MarketsandMarkets, the surgical lasers market is expected to reach $2.37 billion by 2021, growing at a compound annual growth rate of 5.1% from 2016 to 2021. Factors driving market growth include technological advancements in surgical lasers, high prevalence of chronic diseases, a growing preference for minimally invasive surgeries, and more.
Read More
In Britain, diagnoses of children with sleeping disorders has increased by about ten percent in...
